Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.
about
Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeMethadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and MetabolismAn Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS PatientsTwo Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular AntipsychoticsEffect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.Population Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.Frequent malaria illness episodes in two Malawian patients on antiretroviral therapy soon after stopping cotrimoxazole preventive therapy.Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.
P2860
Q28392069-E220F2D2-0D88-41EC-AAFF-46AF9C756EC5Q36342286-198C8611-C07F-40D1-ACDD-BE40215F09EBQ36437792-E4410BC9-8B0B-4928-954C-3740866147D1Q37212537-F06DE41F-6A91-41EA-85FC-3F26726AA76AQ37509532-D27F0031-41C5-44F0-A25D-2A3892500650Q37714285-F450D344-8FCE-4C99-B2E8-AC76C83148B4Q38755666-88A01FB7-AFAA-4831-AA38-555834FA9372Q40190013-853BE353-B7B1-46F2-B876-70DAA10A8DFBQ47906608-3B1759A3-2B05-4460-82EE-D97FF6EC63C3Q51365463-F78E5D83-B229-47A6-8A9C-6F31881F7B23Q52330065-18AFC1C4-EE65-4D23-89B2-F81FDF0B61D5
P2860
Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pharmacogenetics of CYP2B6, CY ...... s on efavirenz and nevirapine.
@en
type
label
Pharmacogenetics of CYP2B6, CY ...... s on efavirenz and nevirapine.
@en
prefLabel
Pharmacogenetics of CYP2B6, CY ...... s on efavirenz and nevirapine.
@en
P2860
P1476
Pharmacogenetics of CYP2B6, CY ...... us on efavirenz and nevirapine
@en
P2093
Antoinette Čolić
P2860
P304
P356
10.3109/03602532.2014.982864
P407
P577
2014-11-13T00:00:00Z